UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria

MLA

Dalu Mancama, et al. UCT943, a next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c5ffba5560db512a6cc49ef66c9894e&authtype=sso&custid=ns315887.

APA

Dalu Mancama, Lyn-Marie Birkholtz, Theresa L. Coetzer, Rosemary Rochford, Lubbe Wiesner, Janette Reader, Paolo Denti, Leslie J. Street, Dennis A. Smith, Benjamin Blasco, Rintis Noviyanti, Diego Gonzàlez Cabrera, Kennan C. Marsh, Francisco-Javier Gamo, David A. Fidock, Claire Le Manach, David Waterson, Paul V. Fish, Michael J Witty, … Tanya Paquet. (2018). UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria.

Chicago

Dalu Mancama, Lyn-Marie Birkholtz, Theresa L. Coetzer, Rosemary Rochford, Lubbe Wiesner, Janette Reader, Paolo Denti, et al. 2018. “UCT943, a next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria,” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c5ffba5560db512a6cc49ef66c9894e&authtype=sso&custid=ns315887.